Invesco, a Atlanta-based investment management firm, bought up another clutch of Smith & Nephew (FTSE:SN, NYSE:SNN) shares, taking its total stake in the British medical device company to nearly 12%, according to regulatory filings.
Invesco added more than 18.5 million shares to its holdings in Smith & Nephew, taking its total to nearly 108.2 million shares. That’s a 20.7% increase in its stake, which now amounts to 11.96% of SNN.
As of Oct. 9 Invesco had about $683 billion in assets under management, according to a press release.
SNN shares were down slightly as of about 1:50 p.m. today, trading at $51.46 apiece.
Endeavour Capital buys stake in catheter maker Access Scientific
West Coast venture capital shop Endeavour Capital bought into Access Scientific for an undisclosed amount. Access makes over-wire vascular access devices.
Zimmer files shelf registration
Zimmer (NYSE:ZMH) filed a shelf registration with the SEC for an unspecified offering. Shelf registrations allow companies to register for an offering up to 2 years ahead of time.
BD joins Hurricane Sandy relief effort
Becton Dickinson (NYSE:BDX) pledged $250,000 in cash and up to $250,000 in product donations for the Hurricane Sandy relief efforts and said it will match up to $50,000 worth of employees’ donations to the American Red Cross.
- Abbott (NYSE:ABT): RBC Capital affirms “outperform” rating, $72 price target.
- Becton Dickinson & Co. (NYSE:BDX): Barclays reiterates "under" rating, $82 price target.
- MindRay (NYSE:MR): Jefferies & Co. reiterates "buy" rating, raises price target from $34 to $36.
- Volcano (NSDQ:VOLC): JMP Securities downgrades to "market underperform" rating, sets $20 price target; Leerink Swann maintains "outperform" rating, $32 price target.